Allianz Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,847
| Closed | -$470K | – | 2721 |
|
|
2021
Q2 | $470K | Hold |
2,847
| – | – | ﹤0.01% | 2058 |
|
|
2021
Q1 | $437K | Sell |
2,847
-126,537
| -98% | -$17.2M | ﹤0.01% | 1940 |
|
|
2020
Q4 | $16.2M | Sell |
129,384
-10,883
| -8% | -$1.22M | 0.02% | 684 |
|
|
2020
Q3 | $14.2M | Sell |
140,267
-5,803
| -4% | -$592K | 0.02% | 670 |
|
|
2020
Q2 | $14.2M | Sell |
146,070
-108,772
| -43% | -$10.1M | 0.02% | 760 |
|
|
2020
Q1 | $21.2M | Buy |
254,842
+97,811
| +62% | +$9.54M | 0.03% | 537 |
|
|
2019
Q4 | $17.5M | Sell |
157,031
-41,730
| -21% | -$4.29M | 0.02% | 848 |
|
|
2019
Q3 | $19.7M | Buy |
198,761
+844
| +0.4% | +$83.8K | 0.02% | 777 |
|
|
2019
Q2 | $19.6M | Buy |
197,917
+47,649
| +32% | +$4.55M | 0.02% | 820 |
|
|
2019
Q1 | $16.6M | Sell |
150,268
-96,140
| -39% | -$10M | 0.02% | 847 |
|
|
2018
Q4 | $22.6M | Buy |
246,408
+4,350
| +2% | +$440K | 0.02% | 649 |
|
|
2018
Q3 | $26.7M | Sell |
242,058
-128,555
| -35% | -$13.4M | 0.02% | 727 |
|
|
2018
Q2 | $34.6M | Buy |
370,613
+51,283
| +16% | +$4.42M | 0.03% | 569 |
|
|
2018
Q1 | $26.5M | Buy |
319,330
+48,660
| +18% | +$4.32M | 0.03% | 724 |
|
|
2017
Q4 | $24.6M | Buy |
270,670
+86,109
| +47% | +$7.16M | 0.02% | 879 |
|
|
2017
Q3 | $14.1M | Sell |
184,561
-106,544
| -37% | -$8.05M | 0.01% | 1150 |
|
|
2017
Q2 | $21.8M | Sell |
291,105
-39,220
| -12% | -$2.72M | 0.02% | 920 |
|
|
2017
Q1 | $21.5M | Buy |
330,325
+32,620
| +11% | +$1.92M | 0.02% | 972 |
|
|
2016
Q4 | $16.4M | Buy |
297,705
+207,922
| +232% | +$11.4M | 0.01% | 1129 |
|
|
2016
Q3 | $5.07M | Buy |
89,783
+53,383
| +147% | +$2.62M | ﹤0.01% | 1611 |
|
|
2016
Q2 | $1.52M | Buy |
+36,400
| New | +$1.68M | ﹤0.01% | 2029 |
|
Other funds holding PRAH
Allianz Asset Management's PRAH Position: Q3 2021 in Review
Allianz Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,847 shares — an estimated $470K sold.
Allianz Asset Management first reported a position in PRAH in Q2 2016 and held it in 21 quarters. The position peaked at $34.6M in Q2 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Allianz Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Allianz Asset Management sold 2,847 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $470K.
- Allianz Asset Management first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 21 quarters.
- Allianz Asset Management's PRA Health Sciences, Inc. position peaked at $34.6M in Q2 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.